Last reviewed · How we verify
aluminium oxide
aluminium oxide is a aluminium oxide drug. It is currently in unknown development.
Aluminium oxide works by binding to and neutralizing excess stomach acid.
Aluminium oxide is a small molecule drug in the aluminium oxide class, but its original developer and current owner are unknown. Its target and exact mechanism of action are also unclear. It is not known whether aluminium oxide is FDA-approved or off-patent. As a result, there is limited information available on its approved indications, half-life, bioavailability, and generic manufacturers. Further research is needed to determine the commercial status and key safety considerations of aluminium oxide.
At a glance
| Generic name | aluminium oxide |
|---|---|
| Drug class | aluminium oxide |
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
This helps to reduce heartburn and acid reflux symptoms by creating a protective barrier in the stomach. By neutralizing acid, aluminium oxide can help to heal damaged tissues in the esophagus and reduce discomfort. This can provide relief for people experiencing symptoms of gastroesophageal reflux disease (GERD).
Approved indications
Common side effects
Key clinical trials
- SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation
- Comparison of Nd Yag, Diode and Er:YAG Lasers vs Scalpel in Preprosthetic Vestibuloplasty: Vestibular Depth Gain (NA)
- Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer (PHASE2)
- Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy (PHASE2)
- Non-invasive Vagus Nerve Stimulation for Chronic Musculoskeletal Pain (NA)
- Comparison of Artificial Disc Implants in Cervical Disc Arthroplasty
- Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension (PHASE2)
- A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- aluminium oxide CI brief — competitive landscape report
- aluminium oxide updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about aluminium oxide
What is aluminium oxide?
How does aluminium oxide work?
What drug class is aluminium oxide in?
What development phase is aluminium oxide in?
Related
- Drug class: All aluminium oxide drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing